Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity
Consumer & Worker Safeguards [3]

Every day, Big Banks, Big Polluters, and Big Tech companies are threatening our economy, our environment, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Tell President Biden: Make Meds Affordable

SEND AN EMAIL
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2019-2021

Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling
Globalization & Trade [6]

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives. Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely. For decades, we have fought for progressive alternatives that benefit people and the planet.

President Biden: No Secrecy in Indo-Pacific Trade Talks

Take Action

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

Diabetes

Public Citizen has been assessing the quality and efficacy of drugs and devices since its founding in 1971. We use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to many drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings on drugs. Our advocacy work involving diabetes is below.

If you are interesting in reading our evaluations of the safety and efficacy of medications as well as information on drug side effects and interactions, please visit WorstPills.org

We’ve done an extensive amount of work on several dangerous diabetes drugs. These medications are: rosiglitazone (Avandia), pioglitazone (Actos) and troglitazone (Rezulin). Click on the names of these drugs to view the work we’ve done involving those medications.

More Information on Diabetes

Testimony on Dapagliflozin, July 19, 2011
Position Statement: FDA’s Decision Not to Take Rosiglitazone (Avandia) Off the Market Jeopardizes Public Health, September 23, 2010
Testimony on Rosiglitazone (Avandia) Safety, July 14, 2010
Letter Urging FDA to Halt Rosiglitazone (Avandia) Trial, May 11, 2010
Testimony on Rosiglitazone (Avandia), April 28, 2010
Letter to FDA Praising Food Safety Cautiousness, Attacking Drug Safety Recklessness, March 8, 2010
Life-Threatening Liver Toxicity of Rosiglitazone (Avandia) Shown in New Public Citizen Research Published in Peer-Reviewed Medical Journal, July 22, 2009
Petition to Ban Diabetes Drug Rosiglitazone (Avandia), October 30, 2008
Testimony on Rosiglitazone (Avandia), July 30, 2007
Letter Demonstrating that FDA Knew About Rosiglitazone (Avandia) Dangers, May 22, 2007
Statement: New Evidence Confirms Public Citizen’s Warnings About the Risks of Popular Diabetes Drug Rosiglitazone (Avandia), May 21, 2007
Letter Urging Rejection of Diabetes Drug Muraglitazar (Pargluva), November 21, 2005
Testimony on Diabetes Drug Muraglitazar (Pargluva), September 9, 2005
Testimony on Pramlintide (Symlin), July 26, 2001
Letter in the Lancet on the Availability of Information on Thiazolidinediones, July 15, 2000
Letter Requesting a Criminal Investigation of Warner Lambert/Parke Davis, March 14, 2000
Petition Requesting Updated Labeling for Diabetes drugs Troglitazone (Rezulin), Rosiglitazone (Avandia) and Pioglitazone (Actos), March 7, 2000
Letter in JAMA Responding to Article on the Safety of Withdrawn Drugs, December 2, 1999
Testimony Advising the FDA to Withdraw Troglitazone (Rezulin), March 26, 1999
Letter on Ad for Troglitazone (Rezulin), January 6, 1999
Petition to Ban Troglitazone (Rezulin), July 27, 1998

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work

Donate

Menu

Tell Congress: Pass the Protecting Our Democracy Act

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats

Get Corporate Money Out of Politics

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity

Don’t Let Big Tech Write Our Digital Privacy Laws

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform

Tell President Biden: Make Meds Affordable

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2019-2021

Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling

President Biden: No Secrecy in Indo-Pacific Trade Talks

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

Share

Diabetes

Share

Diabetes

More Information on Diabetes

You might be interested in

Comments on the FDA’s Draft Guidance Regarding Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Petition to the FDA to Ban Pharmacy Compounding of Cesium Chloride

Compounding Pharmacies

Petition to the FDA to Not Allow Marketing of Over-The-Counter Benzocaine Products for Teething in Infants

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work